Abstract:The effects on locomotor response to cocaine challenge, acquisition of cocaine conditioned place preference and cocaine-induced dopamine (DA) release in nucleus accumbens and ventral tegmental area by the non-specific corticotropin-releasing factor (CRF) receptors antagonist alpha-helical CRF, the selective CRF receptor subtype 1 antagonist CP-154,526 and the selective CRF receptor subtype 2 antagonist anti-sauvagine-30 (AS-30) were investigated in rats. Both alpha-helical CRF (10 mug, i.c.v.) and CP-154,526 (3 mug, i.c.v.) decreased the cocaine-induced distance travelled, whereas AS-30 (3 mug, i.c.v.) did not show such an effect. The CRF receptor antagonists also have significant effects on stereotype counts induced by cocaine injection, in which the alpha-helical CRF or CP-154,526 but not AS-30 did significantly reduce the stereotype counts. alpha-Helical CRF (10 mug) prior to each injection of cocaine blocked cocaine conditioned place preference with no significant difference observed in the time spent in the drug-paired side between post- and pre-training and both 1 and 3 mug CP-154,526 also had significant inhibitory effects on cocaine-induced place preference. However, pre-treatment with an i.c.v. infusion of AS-30 (1 or 3 mug) prior to each injection of cocaine did not affect the acquisition of conditioned place preference. The alpha-helical CRF and CP-154,526 reduced extracellular DA levels of nucleus accumbens and ventral tegmental area in response to the injection of cocaine. However, both alpha-helical CRF and CP-154,526 did not modify extracellular DA levels under basal conditions. In contrast, the i.c.v. infusion of AS-30 had no effects on either the basal DA or the cocaine-induced increase in DA release in nucleus accumbens and ventral tegmental area. These findings demonstrate that activation of the CRF receptor is involved in behavioral and neurochemical effects of cocaine challenge and cocaine reward and that the role of CRF receptor subtypes 1 and 2 in cocaine-induced locomotion, reward and DA release is not identical. The CRF receptor subtype 1 is largely responsible for the action of the CRF system on cocaine locomotion and reward. These results suggest that the CRF receptor antagonist, particularly the CRF receptor subtype 1 antagonist, might be of some value in the treatment of cocaine addiction and cocaine-related behavioral disorders.

Effects of Acute “binge” Cocaine on Mrna Levels of Μ Opioid Receptor and Neuropeptides in Dopamine D1 or D3 Receptor Knockout Mice

Erratum To: Chronic Cocaine-Regulated Epigenomic Changes in Mouse Nucleus Accumbens

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

CREB Binding at the Zfp189 Promoter Within Medium Spiny Neuron Subtypes Differentially Regulates Behavioral and Physiological Adaptations over the Course of Cocaine Use.

Cocaine-Induced Chromatin Modifications Associate with Increased Expression and Three-Dimensional Looping of Auts2.

Effects of Cocaine Place Conditioning, Chronic Escalating-Dose “binge” Pattern Cocaine Administration and Acute Withdrawal on Orexin/hypocretin and Preprodynorphin Gene Expressions in Lateral Hypothalamus of Fischer and Sprague–Dawley Rats

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Presynaptic and postsynaptic mesolimbic dopamine D 3 receptors play distinct roles in cocaine versus opioid reward in mice

Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens

Impact of OPRM1 (mu-opioid receptor gene) A112G polymorphism on dual oxycodone and cocaine self-administration behavior in a mouse model

Dopamine-Dependent Responses To Cocaine Depend On Corticotropin-Releasing Factor Receptor Subtypes

Cocaine taking and craving produce distinct transcriptional profiles in dopamine neurons

The Role of the Nucleus Accumbens OXR1 in Cocaine-Induced Locomotor Sensitization

Cocaine induces locomotor sensitization through a dopamine-dependent VTA-mPFC-FrA cortico-cortical pathway in male mice

Disruption of Dopamine D1 Receptor Phosphorylation at Serine 421 Attenuates Cocaine-Induced Behaviors in Mice

RALATIONSHIP BETWEEN THE DEVELOPMENT AND EXPRESSION OF COCAINE‐INDUCED BEHAVIORAL SENSITIZATION AND CHANGES IN FRA‐2 AND SIGMA RECEPTOR GENE AND PROTEIN EXPRESSION: MODULATION BY A SIGMA RECEPTOR ANTAGONIST

Cocaine, via ΔFosB, remodels gene expression and excitability in ventral hippocampus

Electroventilation in the baboon.

Cocaine Modulation of Frontostriatal Expression of Zif268, D2, and 5-Ht2c Receptors in High and Low Impulsive Rats

Lysis of cells in Elodea leaves by pulsed and continuous wave ultrasound.